-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.
-
Summary
-
Mirum Pharmaceuticals, Inc. quarterly/annual Net Income (Loss) Attributable to Parent history and growth rate from Q2 2018 to Q2 2024.
- Mirum Pharmaceuticals, Inc. Net Income (Loss) Attributable to Parent for the quarter ending June 30, 2024 was -$24.6M, a 66.7% increase year-over-year.
- Mirum Pharmaceuticals, Inc. Net Income (Loss) Attributable to Parent for the twelve months ending June 30, 2024 was -$109M, a 38.1% increase year-over-year.
- Mirum Pharmaceuticals, Inc. annual Net Income (Loss) Attributable to Parent for 2023 was -$163M, a 20.5% decline from 2022.
- Mirum Pharmaceuticals, Inc. annual Net Income (Loss) Attributable to Parent for 2022 was -$136M, a 61.5% decline from 2021.
- Mirum Pharmaceuticals, Inc. annual Net Income (Loss) Attributable to Parent for 2021 was -$84M, a 18.7% increase from 2020.
Net Income (Loss) Attributable to Parent, Trailing 12 Months (USD)
Net Income (Loss) Attributable to Parent, Quarterly (USD)
Net Income (Loss) Attributable to Parent, YoY Quarterly Growth (%)